BioSpace News Archive

Yiling Pharmaceutical Exhibiting its Innovative TCM Products during CHEXPO Macau 2022

CHEXPO Macau 2022 was officially opened on October 20, 2022. As one of the top 10 TCM enterprises in China, Yiling Pharmaceutical exhibited a number of its patented TCM and health products during the expo.

October 26, 2022
·
2 min read
Harro Höfliger and LEON collaborate to bring the innovative NANOus LNP-encapsulation device to market for rapid, large-scale prophylactic vaccine manufacturing

LEON and Harro Höfliger to build and commercialize LEON’s NANOus, a novel aseptic manufacturing device to facilitate commercial production of LNP-encapsulated genetic materials and other APIs By enabling easy scale-up, PAT and GMP-compliance,

October 26, 2022
·
5 min read
Genetown

New Data at ECTRIMS 2022 Highlight Biogen’s Commitment to Advancing Individualized Disease Management for People Living with MS

Biogen Inc. announced new data from its industry-leading portfolio of multiple sclerosis therapies being presented at the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis meeting October 26-28, 2022.

October 26, 2022
·
25 min read
Immuron CEO, Steven Lydeamore to present at AusBioInvest 2022

Immuron Limited is pleased to provide investors with a copy of the presentation slide deck to be showcased at AusBioInvest 2022 in Perth, Australia on October 27, 2022, by our Chief Executive Officer, Steven Lydeamore.

October 26, 2022
·
1 min read
Drug Development

Aileron Therapeutics Presents Results from Phase 1 Study in Healthy Volunteers Demonstrating ALRN-6924 Induced Cell Cycle Arrest in Bone Marrow Stem Cells and Hair Follicles at EORTC-NCI-AACR International Conference

Aileron Therapeutics presented detailed results from its completed Phase 1 study of ALRN-6924 in healthy volunteers at the EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics 2022 taking place in Barcelona October 26 – 28, 2022.

October 26, 2022
·
7 min read
Business

Integra LifeSciences Reports Third Quarter 2022 Financial Results

Integra LifeSciences Holdings Corporation, a leading global medical technology company, reported financial results for the third quarter ending September 30, 2022.

October 26, 2022
·
22 min read
Business

Editas Medicine to Host Conference Call Discussing Third Quarter 2022 Results and Corporate Update

Editas Medicine, Inc., a clinical stage genome editing company, announced that it will host a conference call and webcast on Wednesday, November 2, 2022, at 8:00 a.m. ET to provide a corporate update and results for the third quarter of 2022.

October 26, 2022
·
1 min read
Business

Lannett to Report Fiscal 2023 First-Quarter Financial Results, Host Conference Call on Wednesday, November 2

Lannett Company, Inc. announced that it will report financial results for its fiscal 2023 first quarter on Wednesday, November 2, 2022, after the market closes.

October 26, 2022
·
1 min read
VacV Biotherapeutics emerges from stealth mode to bring ground-breaking cancer immunotherapies to the clinic

VacV Biotherapeutics emerges from stealth mode to bring ground-breaking cancer immunotherapies to the clinic Enhanced systemic delivery system using novel Vaccinia virus technology targets a range of cancers .

October 26, 2022
·
4 min read
FDA

Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI™ (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI ™ (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma.

October 26, 2022
·
9 min read